RVMD News
Revolution Medicines, Inc.
$193.52
+$5.08(+2.70%)
35
Overall
40
Value
30
Tech
36
Quality
Market Cap
$41.48B
Volume
2.46M
52W Range
$47.45 - $224.31
Target Price
$253.00
RVMD news: the latest Revolution Medicines, Inc. headlines, press releases and market updates, newest first.
Latest RVMD News
- Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Revolution Medicines (RVMD) and Viridian Therapeutics (VRDN)TipRanks Newsroom · Oct 14, 2026
- Revolution Medicines Draws $250 Million Term Loan FacilityTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Guggenheim Sticks to Its Buy Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Bernstein Sticks to Their Hold Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead AssetNewswire TipRanks · Sep 25, 2026
- Revolution Medicines (RVMD) Gets a Buy from Goldman SachsTipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVMD | $193.52 | +2.7% | 2.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Revolution Medicines, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW